Juncture Wealth Strategies’s Rigel Pharmaceuticals RIGL Stock Holding History

Juncture Wealth Strategies’s Portfolio RIGL Stock Details RIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$220K	Buy	+4,561	New	+$198K	0.06%	177

Other funds holding RIGL

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Venture Visionary Partners Sylvania, Ohio $3.82B AUM 21.33% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

GWM

GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

TCM

Triumph Capital Management Denver, Colorado $573M AUM 15.32% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Juncture Wealth Strategies's RIGL Position: Q3 2026 in Review

Juncture Wealth Strategies opened a new position in Rigel Pharmaceuticals (RIGL) in Q3 2026: 4,561 shares worth $220K. The stake represents 0.06% of the portfolio and ranks #177 among its holdings.

10 funds tracked by Wall St. Rank hold RIGL as of Q3 2026.

Juncture Wealth Strategies held 4,561 shares of Rigel Pharmaceuticals worth $220K as of Q3 2026.
Rigel Pharmaceuticals was a new Juncture Wealth Strategies position in Q3 2026.
Rigel Pharmaceuticals made up 0.06% of Juncture Wealth Strategies's portfolio in Q3 2026, its #177 holding.
10 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2026.

Based on Juncture Wealth Strategies's 13F filing for Q3 2026, filed 6 Oct 2026.